drug

triheptanoin

1 story · latest Oct 19, 2026

Follow triheptanoin. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jun 2020 · NDA213687
Brand: Dojolvi
Code: UX007
Trials: 2 registered trials in coverage

Relationships

Developed by Ultragenyx Pharmaceutical Inc

Timeline

Ultragenyx settles DOJOLVI patent suit with Navinta over generic ANDA

Oct 19Regulatory decisiontriheptanoin Ultragenyx Pharmaceutical Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.